Biochemical characterization of human anti-hepatitis b monoclonal antibody produced in the microalgae phaeodactylum tricornutum

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Vanier, Gaëtan ^a   Hempel, Franziska ^b   Chan, Philippe ^c   Rodamer, Michael ^d   Vaudry, David ^c   Maier, Uwe G ^b   Lerouge, Patrice ^a   Bardor, Muriel ^a,e  

^a UNIVERSITÉ DE ROUEN   (France)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c NORMANDIE UNIVERSITÉ   (France)

^d AGILENT TECHNOLOGIES   (Germany)

^e INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HEPATITIS B MONOCLONAL ANTIBODY; HUMAN MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ALPHA-1,3-MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE I; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINYLTRANSFERASE; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; BIOCHEMICAL ANALYSIS; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; CYTOLOGY; DRUG MANUFACTURE; DRUG QUALITY; GLYCOSYLATION; N GLYCOSYLATION; NONHUMAN; PHAEODACTYLUM TRICORNUTUM; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; BIOREACTOR; BIOSYNTHESIS; BIOTECHNOLOGY; DIATOM; DRUG STABILITY; ENDOPLASMIC RETICULUM; HUMAN; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; MICROALGA; MOLECULAR GENETICS; PROCEDURES; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BIOREACTORS; BIOTECHNOLOGY; DIATOMS; DRUG STABILITY; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN G; MASS SPECTROMETRY; MICROALGAE; MOLECULAR SEQUENCE DATA; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; PROTEOLYSIS; RECOMBINANT FUSION PROTEINS;

EID: 84947212626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139282     Document Type: Article

References (69)

1. Walsh G. Biopharmaceutical benchmarks 2010. Nat Biotechnol. 2010; 28: 917-924. doi: 10.1038/nbt0910-917 PMID: 20829826
2. Aggarwal S. What's fueling the biotech engine-2010 to 2011. Nat Biotechnol. 2011; 29: 1083-1089. doi: 10.1038/nbt.2060 PMID: 22158359
3. Elvin JG, Couston RG, van der Walle CF. Therapeutic antibodies: Market considerations, disease targets and bioprocessing. Int J Pharm. 2013; 440: 83-98. doi: 10.1016/j.ijpharm.2011.12.039 PMID: 22227342
4. Jayapal KP, Wlaschin KF, Hu W, Yap MG. Recombinant protein therapeutics from CHO cells-20 years and counting. Chem Eng Prog. 2007; 103: 40.
5. Beck A, Reichert JM. Marketing approval of mogamulizumab. mAbs. 2012; 4: 419-425. doi: 10.4161/mabs.20996 PMID: 22699226
6. Rasala BA, Mayfield SP. Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses. Photosynth Res. 2014; 1-13. doi: 10.1007/s11120-014-9994-7 PMID: 24659086
7. Mathieu-Rivet E, Kiefer-Meyer M-C, Vanier G, Ovide C, Burel C, Lerouge P, et al. Protein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals. Plant Physiol. 2014; 5: 359. doi: 10.3389/fpls.2014.00359
8. Baïet B, Burel C, Saint-Jean B, Louvet R, Menu-Bouaouiche L, Kiefer-Meyer M-C, et al. N-glycans of Phaeodactylum tricornutum diatom and functional characterization of its N-Acetylglucosaminyltransferase I enzyme. J Biol Chem. 2011; 286: 6152-6164. doi: 10.1074/jbc.M110.175711 PMID: 21169367
9. Levy-Ontman O, Arad SM, Harvey DJ, Parsons TB, Fairbanks A, Tekoah Y. Unique N-glycan moieties of the 66-kDa cell wall glycoprotein from the red microalga Porphyridium sp. J Biol Chem. 2011; 286: 21340-21352. doi: 10.1074/jbc.M110.175042 PMID: 21515680
10. Mathieu-Rivet E, Scholz M, Arias C, Dardelle F, Schulze S, Mauff FL, et al. Exploring the N-glycosylation Pathway in Chlamydomonas reinhardtii Unravels Novel Complex Structures. Mol Cell Proteomics. 2013; 12: 3160-3183. doi: 10.1074/mcp.M113.028191 PMID: 23912651
11. Levy-Ontman O, Fisher M, Shotland Y, Weinstein Y, Tekoah Y, Arad SM. Genes involved in the endoplasmic reticulum N-glycosylation pathway of the red microalga Porphyridium sp.: a bioinformatic study. Int J Mol Sci. 2014; 15: 2305-2326. doi: 10.3390/ijms15022305 PMID: 24514561
12. Lingg N, Zhang P, Song Z, Bardor M. The sweet tooth of biopharmaceuticals: Importance of recombinant protein glycosylation analysis. Biotechnol J. 2012; 7: 1462-1472. doi: 10.1002/biot.201200078 PMID: 22829536
13. Rosales-Mendoza S, Paz-Maldonado LMT, Soria-Guerra RE. Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives. Plant Cell Rep. 2011; 31: 479-494. doi: 10.1007/s00299-011-1186-8 PMID: 22080228
14. Mayfield SP, Franklin SE, Lerner RA. Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci. 2003; 100: 438-442. PMID: 12522151
15. Eichler-Stahlberg A, Weisheit W, Ruecker O, Heitzer M. Strategies to facilitate transgene expression in Chlamydomonas reinhardtii. Planta. 2009; 229: 873-883. doi: 10.1007/s00425-008-0879-x PMID: 19127370
16. Rasala BA, Muto M, Lee PA, Jager M, Cardoso RMF, Behnke CA, et al. Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii: Production of therapeutic proteins in algae. Plant Biotechnol J. 2010; 8: 719-733. doi: 10. 1111/j.1467-7652.2010.00503.x PMID: 20230484
17. Tran M, Zhou B, Pettersson PL, Gonzalez MJ, Mayfield SP. Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol Bioeng. 2009; 104: 663-673. doi: 10. 1002/bit.22446 PMID: 19562731
18. Hempel F, Lau J, Klingl A, Maier UG. Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutum. PLoS ONE. 2011; 6: e28424. doi: 10.1371/journal.pone.0028424 PMID: 22164289
19. Hempel F, Maier UG. An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency. Microb Cell Factories. 2012; 11: 126. doi: 10.1186/1475-2859-11-126
20. Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci. 2008; 97: 2426-2447. doi: 10.1002/jps.21180 PMID: 17828757
21. Brorson K, Jia AY. Therapeutic monoclonal antibodies and consistent ends: terminal heterogeneity, detection, and impact on quality. Curr Opin Biotechnol. 2014; 30: 140-146. doi: 10.1016/j.copbio.2014. 06.012 PMID: 25022603
22. Luo J, Zhang J, Ren D, Tsai W-L, Li F, Amanullah A, et al. Probing of C-terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media. Biotechnol Bioeng. 2012; 109: 2306-2315. doi: 10.1002/bit.24510 PMID: 22473810
23. Tang L, Sundaram S, Zhang J, Carlson P, Matathia A, Parekh B, et al. Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry. mAbs. 2013; 5: 114-125. doi: 10.4161/mabs.22695 PMID: 23222183
24. Stern B, Olsen LC, Trö\s se C, Ravneberg H, Pryme IF. Improving mammalian cell factories: The selection of signal peptide has a major impact on recombinant protein synthesis and secretion in mammalian cells. Trends Cell Mol Biol. 2007; 2: 1-17.
25. Voss M, Schröder B, Fluhrer R. Mechanism, specificity, and physiology of signal peptide peptidase (SPP) and SPP-like proteases. Biochim Biophys Acta BBA-Biomembr. 2013; 1828: 2828-2839. doi: 10.1016/j.bbamem.2013.03.033
26. Bowler C, Allen AE, Badger JH, Grimwood J, Jabbari K, Kuo A, et al. The Phaeodactylum genome reveals the evolutionary history of diatom genomes. Nature. 2008; 456: 239-244. doi: 10.1038/nature07410 PMID: 18923393
27. Song Z. Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics [Internet]. WO2014058389 A1, 2014. Available: http://www.google.com/patents/WO2014058389A1
28. Zimmermann R, Eyrisch S, Ahmad M, Helms V. Protein translocation across the ER membrane. Biochim Biophys Acta. 2011; 1808: 912-924. doi: 10.1016/j.bbamem.2010.06.015 PMID: 20599535
29. Kober L, Zehe C, Bode J. Optimized signal peptides for the development of high expressing CHO cell lines. Biotechnol Bioeng. 2013; 110: 1164-1173. doi: 10.1002/bit.24776 PMID: 23124363
30. Banerjee S, Vishwanath P, Cui J, Kelleher DJ, Gilmore R, Robbins PW, et al. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc Natl Acad Sci. 2007; 104: 11676-11681. doi: 10.1073/pnas.0704862104 PMID: 17606910
31. Rehder DS, Dillon TM, Pipes GD, Bondarenko PV. Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. J Chromatogr A. 2006; 1102: 164-175. doi: 10.1016/j.chroma.2005.10.053 PMID: 16297926
32. Dick LW, Kim C, Qiu D, Cheng K-C. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides. Biotechnol Bioeng. 2007; 97: 544-553. doi: 10. 1002/bit.21260 PMID: 17099914
33. Kaplan AP, Hood LE, Terry WD, Metzger H. Amino terminal sequences of human immunoglobulin heavy chains. Immunochemistry. 1971; 8: 801-811. PMID: 5135622
34. Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem. 2009; 392: 145-154. doi: 10.1016/j.ab.2009.05.043 PMID: 19497295
35. Song Y, Schowen RL, Borchardt RT, Topp EM. Effect of "pH" on the rate of asparagine deamidation in polymeric formulations: "pH"-rate profile. J Pharm Sci. 2001; 90: 141-156. PMID: 11169531
36. Stratton LP, Kelly RM, Rowe J, Shively JE, Smith DD, Carpenter JF, et al. Controlling deamidation rates in a model peptide: Effects of temperature, peptide concentration, and additives. J Pharm Sci. 2001; 90: 2141-2148. doi: 10.1002/jps.1165 PMID: 11745773
37. Domon B, Costello CE. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj J. 1988; 5: 397-409. doi: 10.1007/BF01049915
38. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Marth JD, et al. Symbol nomenclature for glycan representation. Proteomics. 2009; 9: 5398-5399. doi: 10.1002/pmic.200900708 PMID: 19902428
39. Tarentino AL, Gomez CM, Plummer TH. Deglycosylation of asparagine-linked glycans by peptide:Nglycosidase F. Biochemistry (Mosc). 1985; 24: 4665-4671. doi: 10.1021/bi00338a028
40. Tretter V, Altmann F, März L. Peptide-N4-(N-Acetyl-beta-glucosaminyl)asparagine amidase F cannot release glycans with fucose attached alpha 1-3 to the asparagine-linked N-Acetylglucosamine residue. Eur J Biochem FEBS. 1991; 199: 647-652.
41. Le Mauff F, Mercier G, Chan P, Burel C, Vaudry D, Bardor M, et al. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants. Plant Biotechnol J. 2014; n/a-n/a. doi: 10.1111/pbi.12301 PMID: 25523794
42. Taga EM, Waheed A, Van Etten RL. Structural and chemical characterization of a homogeneous peptide N-glycosidase from almond. Biochemistry (Mosc). 1984; 23: 815-822.
43. Liu B, Spearman M, Doering J, LattováE, Perreault H, Butler M. The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody. J Biotechnol. 2014; 170: 17-27. doi: 10.1016/j.jbiotec.2013.11. 007 PMID: 24286971
44. Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, et al. Function and glycosylation of plantderived antiviral monoclonal antibody. Proc Natl Acad Sci U S A. 2003; 100: 8013-8018. doi: 10.1073/pnas.0832472100 PMID: 12799460
45. Sriraman R, Bardor M, Sack M, Vaquero C, Faye L, Fischer R, et al. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-Alpha(1,3)-fucose residues. Plant Biotechnol J. 2004; 2: 279-287. PMID: 17134389
46. Triguero A, Cabrera G, Cremata JA, Yuen C-T, Wheeler J, Ramírez NI. Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans. Plant Biotechnol J. 2005; 3: 449-457. doi: 10.1111/j.1467-7652.2005.00137.x PMID: 17173632
47. Petruccelli S, Otegui MS, Lareu F, Tran Dinh O, Fitchette A-C, Circosta A, et al. A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol J. 2006; 4: 511-527. doi: 10.1111/j.1467-7652.2006.00200.x PMID: 17309727
48. Triguero A, Cabrera G, Royle L, Harvey DJ, Rudd PM, Dwek RA, et al. Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants. Anal Biochem. 2010; 400: 173-183. doi: 10.1016/j.ab.2010.01.027 PMID: 20109437
49. De Meyer T, Depicker A. Trafficking of endoplasmic reticulum-retained recombinant proteins is unpredictable in Arabidopsis thaliana. Plant Physiol. 2014; 5: 473. doi: 10.3389/fpls.2014.00473
50. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985; 316: 452-457. doi: 10.1038/316452a0 PMID: 3927174
51. Jefferis R, Lund J, Pound JD. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev. 1998; 163: 59-76. PMID: 9700502
52. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the Immune System. Science. 2001; 291: 2370-2376. doi: 10.1126/science.291.5512.2370 PMID: 11269318
53. Raju TS, Briggs JB, Borge SM, Jones AJS. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology. 2000; 10: 477-486. doi: 10.1093/glycob/10.5. 477 PMID: 10764836
54. Elbers IJW, Stoopen GM, Bakker H, Stevens LH, Bardor M, Molthoff JW, et al. Influence of Growth Conditions and Developmental Stage onN-Glycan Heterogeneity of Transgenic Immunoglobulin G and Endogenous Proteins in Tobacco Leaves. Plant Physiol. 2001; 126: 1314-1322. doi: 10.1104/pp.126. 3.1314 PMID: 11457982
55. Holland T, Sack M, Rademacher T, Schmale K, Altmann F, Stadlmann J, et al. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture. Biotechnol Bioeng. 2010; 107: 278-289. doi: 10.1002/bit.22800 PMID: 20506104
56. Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 2009; 19: 936-949. doi: 10.1093/glycob/cwp079 PMID: 19494347
57. Butler M. Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems. Cytotechnology. 2006; 50: 57-76. doi: 10.1007/s10616-005-4537-x PMID: 19003071
58. Arcalis E, Stadlmann J, Rademacher T, Marcel S, Sack M, Altmann F, et al. Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins. Plant Mol Biol. 2013; 83: 105-117. doi: 10.1007/s11103-013-0049-9 PMID: 23553222
59. Aghamohseni H, Ohadi K, Spearman M, Krahn N, Moo-Young M, Scharer JM, et al. Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody. J Biotechnol. 2014; 186: 98-109. doi: 10.1016/j.jbiotec.2014.05.024 PMID: 25014402
60. Ivarsson M, Villiger TK, Morbidelli M, Soos M. Evaluating the impact of cell culture process parameters on monoclonal antibody N-glycosylation. J Biotechnol. 2014; 188: 88-96. doi: 10.1016/j.jbiotec.2014. 08.026
61. Leatherbarrow RJ, Dwek RA. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay. Mol Immunol. 1984; 21: 321-327. PMID: 6610105
62. Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, Goodall M, et al. Role of Oligosaccharide Residues of IgG1-Fc in Fc?RIIb Binding. J Biol Chem. 2001; 276: 45539-45547. PMID: 11567028
63. Jefferis R. Glycosylation of Recombinant Antibody Therapeutics. Biotechnol Prog. 2005; 21: 11-16. doi: 10.1021/bp040016j PMID: 15903235
64. Wright A, Morrison SL. Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells. J Immunol. 1998; 160: 3393-3402. PMID: 9531299
65. Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, et al. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology. 2011; 21: 949-959. doi: 10.1093/glycob/cwr027 PMID: 21421994
66. Alessandri L, Ouellette D, Acquah A, Rieser M, LeBlond D, Saltarelli M, et al. Increased serum clearance of oligomannose species present on a human IgG1 molecule. mAbs. 2012; 4: 509-520. doi: 10. 4161/mabs.20450 PMID: 22669558
67. Weinreb NJ. Imiglucerase and its use for the treatment of Gaucher's disease. 2008; Available: http://informahealthcare.com/doi/abs/10.1517/14656566.9.11.1987
68. Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J. 2007; 5: 579-590. PMID: 17524049
69. He X, Galpin JD, Tropak MB, Mahuran D, Haselhorst T, von Itzstein M, et al. Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants. Glycobiology. 2012; 22: 492-503. doi: 10.1093/glycob/cwr157 PMID: 22061999